Completed NA INTERVENTIONAL 3-arm NCT01094080

Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health (BEMIM)

Sponsor: HiPP GmbH & Co. Vertrieb KG

Interventions breast milk modified infant formula standard infant formula

Updated 9 times since 2017 Last updated: Sep 1, 2020 Started: Feb 28, 2010 Primary completion: Sep 30, 2011 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Infant Nutrition, this trial is completed. The trial is conducted by HiPP GmbH & Co. Vertrieb KG and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 4 earlier versions

Jun 2020 — Oct 2020 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Jun 2020 [monthly]

Active Not Recruiting NA
Oct 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

Status: Completed → Active Not Recruiting
Jan 2017 — Oct 2017 [monthly]

Completed NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HiPP GmbH & Co. Vertrieb KG
Ludwig-Maximilians - University of Munich

Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belgrade, Serbia
• München, Germany